Next Oncology ( Site 0001)

San Antonio, Texas 78229

0 studies enrolling now · 3 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Neoplasms, Solid Tumors

Studies at this site

• A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) — Completed
• A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001) — Running, not enrolling
• Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014) — Completed